FOXP3 and systemic lupus erythematosus: To determine whether the increase in CD4+CD25-Foxp3+ T cells in SLE patients is linked to a higher clinical disease activity, SLE patients were divided into patients with active (SLEDAI score ≥6) and inactive (SLEDAI score <6) disease (Figure 1c).